Introduction
============

*Edwardsiella tarda*, a member of the family Enterobacteriaceae, is a motile, facultatively anaerobic, Gram-negative rod that has been isolated from fresh and brackish water environments and a variety of animals (reptiles, amphibians, and fish, including catfish and eels) ([@B1],[@B2]). In humans, *E. tarda* is a rare pathogen that mainly causes gastroenteritis as a food-borne infection ([@B3]). Extraintestinal *E. tarda* infections have also been reported infrequently. The risk factors for extraintestinal infections include hepatobiliary diseases, malignancy, and diabetes mellitus ([@B4]).

We describe the first case of *E. tarda* bacteremia with psoas abscess, vertebral osteomyelitis, and spinal epidural abscess. The patient had frequently eaten raw fish and grilled eel. She was simultaneously diagnosed with recurrent gastric cancer presenting as peritoneal dissemination. We also review the published English case reports of *E. tarda* bacteremia in Japan and the experience at our hospital.

Case Report
===========

A 65-year-old Japanese woman was admitted to our hospital with a fever, lumbago, and right groin pain that had persisted for 2 weeks. The patient had undergone total gastrectomy with cholecystectomy and splenectomy for advanced gastric cancer (stage IIIC) three years earlier followed by oral chemotherapy for one year and had since been relapse-free. She had chronic diarrhea. She drank 360 mL of *sake* (Japanese rice wine) per day. A dietary history revealed that she had frequently eaten *sashimi* (sliced raw fish) and grilled eel, including within a few days prior to the onset of symptoms.

On a physical examination, the patient appeared ill, with a temperature of 36.7°C, pulse of 67 beats/min, blood pressure of 83/51 mmHg, and a respiratory rate of 18 breaths/min. The cardiovascular and respiratory findings were unremarkable. There was bilateral costovertebral angle tenderness and knocking pain of the lumbar spine. There was no abdominal tenderness. An initial hematological investigation revealed a white blood cell count of 13.7×10^3^/μL with 86% neutrophils, hemoglobin 9.9 g/dL, urea nitrogen 30.2 mg/dL, creatinine 0.91 mg/dL, albumin 1.7 g/dL, and C-reactive protein 19.8 mg/dL. Liver enzyme levels were normal. Urinary sediment revealed a white blood cell count of ＞100/high-powered field (HPF) and a red blood cell count of 10 to 19/HPF.

Abdominal contrast-enhanced computed tomography (CT) revealed bilateral renal enlargement with perinephric stranding and a bilateral psoas abscess ([Figure a](#g001){ref-type="fig"}). Magnetic resonance imaging (MRI) of the lumbar spine revealed vertebral osteomyelitis on the L2 to L4 vertebral bodies and disk space.

![(a) A coronal contrast-enhanced computed tomography scan of the abdomen on admission showing a large, fluid-containing lesion with rim enhancement in the right psoas muscle and similar small lesions in the left psoas muscle (arrows). (b) T1-weighted magnetic resonance imaging of the lumbar spine with gadolinium enhancement on day 10 showing high intensity at the L2 to L4 vertebrae and epidural lesion with rim enhancement (arrows).](1349-7235-57-0893-g001){#g001}

Empiric antimicrobial therapy with intravenous ceftriaxone (2 g every 24 hours) was started for urinary tract infection, psoas abscess, and vertebral osteomyelitis. Surgical drainage was not initially performed because of the high risk of postoperative complications due to hypoalbuminemia. The next day, the blood cultures became positive for a Gram-negative rod identified as *Edwardsiella tarda* by the RAISUS (Nissui Pharmaceutical, Tokyo, Japan) with susceptibility to ampicillin/sulbactam (minimum inhibitory concentration ≤4 μg/mL), piperacillin/tazobactam (≤8 μg/mL), cefazoline (≤2 μg/mL), cefmetazole (≤8 μg/mL), cefotaxime (≤1 μg/mL), cefepime (≤1 μg/mL), aztreonam (≤4 μg/mL), meropenem (≤1 μg/mL), amikacin (≤8 μg/mL), and levofloxacin (≤1 μg/mL) and resistance to gentamicin (＞8 μg/mL) and trimethoprim/sulfamethoxazole (＞80 μg/mL). The organism was also isolated from urine culture on the day of admission but not from stool culture.

On day 5, based on the susceptibility testing, treatment with ceftriaxone was changed to intravenous cefmetazole (1 g every 6 hours). On day 24, the patient underwent surgical drainage and discectomy because the bilateral psoas abscess was gradually increasing in size and a spinal epidural abscess appeared ([Figure b](#g001){ref-type="fig"}). No organisms grew from the abscess cultures. On day 38, she developed right lower abdominal pain. Abdominal CT revealed ileocecal diverticulitis, and cefmetazole was changed to meropenem (1 g every 8 hours). She underwent a barium enema and colonoscopy, which revealed multiple colon strictures. The pathological tissue revealed malignant cells in the membrane of the rectum above the peritoneal reflection, which were considered to be due to peritoneal dissemination of recurrent gastric cancer. Treatment with meropenem was continued, and her symptoms gradually improved. On day 85, she was discharged after 12 weeks of intravenous antimicrobial therapy.

Discussion
==========

To our knowledge, this is the first case of *E. tarda* bacteremia with psoas abscess, vertebral osteomyelitis, and spinal epidural abscess. In humans, *E. tarda* infections can be divided into two broad categories: gastrointestinal and extraintestinal. In ＞80% of all cases reported, *E. tarda* is cultured from fecal specimens from patients in either the symptomatic or the asymptomatic carrier state ([@B2]). However, severe extraintestinal infections have also been reported, including bacteremia, wound infection, necrotizing fasciitis, hepatobiliary infection (liver abscess, cholecystitis), meningitis, osteomyelitis, urinary tract infection, endocarditis, tubo-ovarian abscess, salpingitis, brain abscess, and empyema ([@B1]-[@B10]). Historically, this organism is commonly found in both fresh and brackish water environments and in a variety of animals (reptiles, amphibians, and fish, including catfish and eels), and it can also cause disease in these animals ([@B1]-[@B3]). *E. tarda* has been isolated from 72% of farm-cultured eels in the Republic of Korea ([@B11]). In contrast, *E. tarda* is not a member of the normal human flora, being isolated from only 0.0073% of fecal specimens from healthy Japanese ([@B12]). Therefore, *E. tarda* infection is considered to be food-borne, transmitted to humans by ingestion of contaminated food such as raw seafood ([@B3]).

Risk factors for *E. tarda* infection are wounding in aquatic environments, exposure to infected animals, dietary habits, and chronic underlying conditions ([@B2]). *Aeromonas* species (such as *Aeromonas hydrophila*) and *Vibrio vulnificus* are also known as aquatic pathogens. *Aeromonas* spp. are most commonly isolated from warm fresh and brackish waters, whereas *V. vulnificus* is most commonly isolated from brackish and marine environments ([@B13]). In humans, these pathogens can cause serious infections, such as bacteremia and necrotizing fasciitis, following ingestion of raw seafood or aquatic injury or exposure. Most patients infected with these pathogens are immunocompromised hosts, notably those with liver cirrhosis. Therefore, the clinical characteristics of *E. tarda* human infections and the environmental risks are similar to those of *Aeromonas* spp. and *V. vulnificus*.

In our patient, *E. tarda* was isolated from both blood and urine cultures. The patient did not have close contact with domestic or wild animals or any marine exposure prior to the onset of infection. However, she had frequently eaten *sashimi* and grilled eel. Therefore, the organism may have caused gastrointestinal colonization through the patient\'s ingestion of raw fish and grilled eels and may have resulted in retrograde urinary tract infection ([@B6]), although a stool culture was negative for the pathogen.

In previous reports, the major underlying conditions in *E. tarda* bacteremia were hepatobiliary diseases (liver cirrhosis, gallbladder stones, and ethanol abuse), malignancy (hepatobiliary and gastrointestinal tract), and iron overload states (sickle cell disease, leukemia, and neonatal state) ([@B2],[@B3]). Although *E. tarda* bacteremia is a rare complication (＜5%), the mortality rate is high, at nearly 50% ([@B1]-[@B3]). *E. tarda* is usually susceptible to most antimicrobials for Gram-negative bacteria except colistin and polymyxin B ([@B1],[@B2]). The most frequently reported geographical area of *E. tarda* bacteremia cases is Japan, followed by the United States and the Republic of China ([@B3]). Japan has one of the world\'s highest rates of seafood consumption. We reviewed all case reports of *E. tarda* bacteremia in Japan published in English using PubMed. To date, 16 such cases have been reported ([@B6],[@B14]-[@B16]). In addition, our hospital encountered five cases of *E. tarda* bacteremia from 2008 to 2016 ([Table](#t001){ref-type="table"}). The median age of the 21 patients with *E. tarda* bacteremia was 75 years (range, 56-101 years), and 11 patients were men (52.4%). Almost all patients with *E. tarda* bacteremia have significant underlying diseases; the major underlying disease was malignancy \[13 of 17 (76.5%)\], and the gastrointestinal tract was the most commonly affected organ \[7 of 13 (53.8%)\], followed by the hepatobiliary tract \[4 of 13 (30.8%)\]. Three patients required surgical treatment (one case was inoperable), and the overall mortality in our review was 38.1% (8 of 21 cases). Three patients (cases 16, 19, and 21 in [Table](#t001){ref-type="table"}) had previously undergone gastrectomy. We speculate that gastrectomy may increase the risk of *E. tarda* bacteremia, as it increases the risk of typhoid fever, due to a reduction of gastric acid secretion ([@B17]). In our patient, postgastrectomy state and the undiagnosed recurrent gastric cancer presenting as peritoneal dissemination probably contributed to the development of *E. tarda* bacteremia, and chronic alcohol consumption may also have contributed. Consequently, clinicians should consider underlying immunosuppressive conditions, including recurrent cancer, in patients with *E. tarda* bacteremia.

###### 

Summary of the 21 Cases of *Edwardsiella tarda* Bacteremia Reported in Japan: 16 Cases Reported in English and 5 Cases from Our Hospital over the Past 9 Years.

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Case no.   Age (y),\   Symptoms                                    Underlying disease                                                                     Complication/Focus                                               Other sources of isolation   Treatment                                                            Surgery                                                                                Outcome     Reference no. or our hospital case
             Sex                                                                                                                                                                                                                                                                                                                                                                                                                  
  ---------- ----------- ------------------------------------------- -------------------------------------------------------------------------------------- ---------------------------------------------------------------- ---------------------------- -------------------------------------------------------------------- -------------------------------------------------------------------------------------- ----------- ------------------------------------
  1          69, F       Fatigue, generalized edema                  Uterine cancer (intraurethral stent)                                                   Urosepsis                                                        Urine                        Cefoperazone                                                         No                                                                                     Died        6

  2          56, F       Fever, diarrhea, vomiting, abdominal pain   Acute myeloid leukemia, (chemotherapy), rectal cancer                                  Gastroenteritis                                                  Stool                        Cefmetazole and gentamicin                                           No                                                                                     Recovered   14

  3          85, F       Fever, nausea, diarrhea                     Thyroid cancer (thyroidectomy), diabetes mellitus                                      Gastroenteritis, liver abscess                                   Stool, pus                   Meropenem, levofloxacin, cefoperazone/sulbactam, cefcapene pivoxil   Yes; percutaneous drainage                                                             Recovered   15

  4          77, M       NR                                          Cerebral infarction                                                                    Unclear                                                          NR                           NR                                                                   NR                                                                                     Recovered   15

  5          79, M       NR                                          NR                                                                                     Liver abscess                                                    NR                           NR                                                                   NR                                                                                     Recovered   15

  6          70, F       NR                                          NR                                                                                     Cholecystitis                                                    NR                           NR                                                                   NR                                                                                     Recovered   15

  7          89, F       NR                                          Advanced colon cancer                                                                  Unclear                                                          NR                           NR                                                                   NR                                                                                     Recovered   15

  8          61, M       NR                                          NR                                                                                     Colon diverticulitis                                             NR                           NR                                                                   NR                                                                                     Recovered   15

  9          87, M       NR                                          Liver cancer                                                                           Unclear                                                          NR                           NR                                                                   NR                                                                                     Died        15

  10         62, M       NR                                          Abscess around the subscapularis muscle                                                Infected aneurysm                                                NR                           NR                                                                   NR                                                                                     Died        15

  11         92, M       NR                                          Advanced colon cancer                                                                  Unclear                                                          NR                           NR                                                                   NR                                                                                     Died        15

  12         88, F       NR                                          Cholangiocarcinoma                                                                     Unclear                                                          NR                           NR                                                                   NR                                                                                     Died        15

  13         75, F       NR                                          NR                                                                                     Cholecystitis                                                    NR                           NR                                                                   NR                                                                                     Recovered   15

  14         101, F      NR                                          Bile duct stone                                                                        Acute cholangitis                                                NR                           NR                                                                   NR                                                                                     Recovered   15

  15         58, M       NR                                          Gallbladder cancer                                                                     Gallbladder                                                      NR                           NR                                                                   NR                                                                                     Died        15

  16         78, M       Fever, chill                                Gastric cancer (pancreatoduodenectomy)                                                 Cholangitis                                                      None                         Cefmetazole                                                          No                                                                                     Recovered   16

  17         73, F       Abdominal pain                              Malignant lymphoma of small intestine                                                  Peritonitis associated with small-intestinal perforation         None                         Cefmetazole and amikacin                                             No (inoperable)                                                                        Died        Our hospital

  18         80, M       Fever, nausea, right hypochondralgia        Choledocholith, hepatitis C                                                            Cholecystitis                                                    None                         Meropenem, cefotaxime                                                No                                                                                     Recovered   Our hospital

  19^a^      71, M       Fever                                       Gastric cancer with liver metastasis (gastrectomy, chemotherapy)                       Unclear                                                          None                         Cefmetazole                                                          No                                                                                     Recovered   Our hospital

  20^b^      69, M       Fever, abdominal pain                       Biliary cancer (stenting, chemotherapy)                                                Cholangitis                                                      Bile^c^                      Cefotaxime and vancomycin, meropenem and vancomycin                  Yes; endoscopic nasobiliary drainage, percutaneous transhepatic gallbladder drainage   Died        Our hospital

  21         65, F       Fever, chills, lumbago, chronic diarrhea    Gastric cancer (gastrectomy, cholecystectomy, splenectomy, chemotherapy), alcoholism   Psoas and epidural abscess, vertebral osteomyelitis, urosepsis   Urine                        Ceftriaxone, cefmetazole, meropenem                                  Yes; surgical drainage, discectomy                                                     Recovered   Our hospital (present case)
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

^a^α-*Streptococcus* was isolated concurrently with *E. tarda*. ^b^*Klebsiella pneumoniae* was isolated concurrently with *E. tarda*. ^c^*Escherichia coli*, *K. pneumoniae*, *Enterococcus faecium*, and *Candida glabratawere* isolated concurrently with *E. tarda*.

NR: not reported

In conclusion, we have described the first case of *E. tarda* bacteremia with psoas abscess, vertebral osteomyelitis, and spinal epidural abscess, which was successfully treated with antimicrobials and surgery. Although *E. tarda* is a rare pathogen, it can cause fatal infections, like those caused by *Aeromonas* spp. and *Vibrio vulnificus*. Avoidance of consumption of raw or undercooked food is a simple measure to prevent fatal food-borne infections, and it is prudent for clinicians to emphasize the importance of this, especially in patients at high risk.
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